 |
| February
5, 2026 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
- Axon Neuroscience: Immunotherapy Selected
for a Landmark Combination-Therapy Alzheimer’s
Clinical Trial in US, Supported by a USD 151
Million Grant
More
- Braveheart Bio: Senior Leadership
Appointments to Strengthen Scientific and
Operational Capabilities While Advancing
Global Phase 3 Development More
- Brightseed: Peer-Reviewed Clinical Trial
Demonstrates Novel Bioactives Improve Glycemic
Control in Adults With Prediabetes More
- Calico: Appoints Joseph R. Arron, M.D.,
Ph.D., as Head of Human Biology and Genetics More
- Exicure: Publication in Annals of Hematology
Highlighting Rapid Stem Cell Mobilization With
Burixafor in Patients With Multiple Myeloma
and Lymphoma Undergoing Transplant More
- Orca Bio: Presents New Data at the 2026
Tandem Meetings of ASTCT and CIBMTR
Reinforcing Orca-T as a Durable,
High-Precision Cell Therapy for Hematological
Malignancies More
- PharosAI and 10x Genomics: Partner to
Transform Cancer Research With AI and Spatial
Biology More
- Providence Medical Technology: Appoints
Industry Veteran Jim Hens as Chief
Commercial Officer as the Company Continues
Rapid Growth Following Publication of
Landmark Study More
- RenovoRx: Appoints Experienced Public
Company Executive Mark Voll as Chief
Financial Officer More
- Tempest: Closing of Strategic Acquisition
of Dual-Targeting CAR-T Assets
More
- Visby
Medical: Collaborates With Watchmaker Genomics
to Enhance Respiratory Pathogen Detection in
the At-Home Setting More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Eikon Therapeutics: Pricing of Upsized
Initial Public Offering More More
- Exclusive VC Funding Data from BYTE51,
with Special Big4Bio Pricing More
- Midi Health Raises $100M as It Plans
Expansion Into Urgent Care, Research More*
More
More
- Profusa: 1-for-75 Reverse Stock Split More
|
|
 |
| San
Francisco's most flexible contract
vivarium lab space: Start with a
few cages and grow. |
|
Learn More
→ |
|
|
- More on Cellares Automating Manufacturing
and Release Testing for Gene-Edited HSC
Therapies for Stanford Medicine More
- More on Hims Adding Grail’s Cancer Test Amid
Questions About Widespread Use
More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Every Moment
Matters: The Power of Study Director–Advisor
Partnerships Podcast
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- Janux Hires CMO After T Cell Engager Deal
With Bristol Myers; a Batch of Appointments at
Lexeo More*
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
